Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.
By checking this box I consent to the use of my information provided for email marketing purposes.
In each episode Prof. David Nutt is joined by leading experts to discuss research, harm reduction, drug policy, and the science behind drugs
MDMA for Alcohol Use Disorder
Women in Psychedelic Science - Part 3
What would a regulated stimulant market look like?
Investing in Psychedelic Companies
Psilocybin Treatment for Depression - Clinical Insights
Psilocybin Treatment for Depression - Patient Perspective
Street Drug Discussions - Deep Dive into Alcohol
In My Professional Opinion - Vaping and Tobacco Harm Reduction
Women in Psychedelic Science - Part 2
In My Professional Opinion - Healing Sexual Trauma with Entheogens and Psychedelics
Study Drug Sessions - Insights on psychedelic microdosing
How to Prescribe Medical Cannabis in the UK
Professor David Nutt: Back to the Future - Resurrecting Psychedelics in Psychiatry
An unholy triangle? Evidence, politics and uncertainty in drug policy
Clinical Insights - MDMA for Alcohol Use Disorder
Study Drug Sessions - Sex, sexuality and body image